Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083291253> ?p ?o ?g. }
- W2083291253 endingPage "528" @default.
- W2083291253 startingPage "512" @default.
- W2083291253 abstract "Formyl peptide receptors (FPRs) play an essential role in the regulation of endogenous inflammation and immunity. In the present studies, a large series of pyridazin-3(2H)-one derivatives bearing an arylacetamide chain at position 2 was synthesized and tested for FPR agonist activity. The pyridazin-3(2H)-one ring was confirmed to be an appropriate scaffold to support FPR agonist activity, and its modification at the 4 and 6 positions led to the identification of additional active agonists, which induced intracellular Ca2+ flux in HL-60 cells transfected with either FPR1, FPR2, or FPR3. Seven formyl peptide receptor 1 (FPR1)-specific and several mixed FPR1/FPR2 dual agonists were identified with low micromolar EC50 values. Furthermore, these agonists also activated human neutrophils, inducing intracellular Ca2+ flux and chemotaxis. Finally, molecular docking studies indicated that the most potent pyridazin-3(2H)-ones overlapped in their best docking poses with fMLF and WKYMVM peptides in the FPR1 and FPR2 ligand binding sites, respectively. Thus, pyridazinone-based compounds represent potential lead compounds for further development of selective and/or potent FPR agonists." @default.
- W2083291253 created "2016-06-24" @default.
- W2083291253 creator A5006261369 @default.
- W2083291253 creator A5006542271 @default.
- W2083291253 creator A5007196139 @default.
- W2083291253 creator A5013186412 @default.
- W2083291253 creator A5019660090 @default.
- W2083291253 creator A5038963650 @default.
- W2083291253 creator A5048007859 @default.
- W2083291253 creator A5059510963 @default.
- W2083291253 creator A5062505353 @default.
- W2083291253 creator A5067011169 @default.
- W2083291253 creator A5076540388 @default.
- W2083291253 creator A5077189123 @default.
- W2083291253 date "2013-06-01" @default.
- W2083291253 modified "2023-10-06" @default.
- W2083291253 title "Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists" @default.
- W2083291253 cites W1487913306 @default.
- W2083291253 cites W1547225172 @default.
- W2083291253 cites W1561782952 @default.
- W2083291253 cites W1990956893 @default.
- W2083291253 cites W1997790241 @default.
- W2083291253 cites W2000832007 @default.
- W2083291253 cites W2002776682 @default.
- W2083291253 cites W2007088929 @default.
- W2083291253 cites W2007552090 @default.
- W2083291253 cites W2018804849 @default.
- W2083291253 cites W2022335174 @default.
- W2083291253 cites W2025478043 @default.
- W2083291253 cites W2026188912 @default.
- W2083291253 cites W2026625700 @default.
- W2083291253 cites W2033757712 @default.
- W2083291253 cites W2034873089 @default.
- W2083291253 cites W2041364314 @default.
- W2083291253 cites W2045608528 @default.
- W2083291253 cites W2052852012 @default.
- W2083291253 cites W2054200154 @default.
- W2083291253 cites W2054802749 @default.
- W2083291253 cites W2054895562 @default.
- W2083291253 cites W2059566065 @default.
- W2083291253 cites W2059617137 @default.
- W2083291253 cites W2060259273 @default.
- W2083291253 cites W2063110060 @default.
- W2083291253 cites W2063672998 @default.
- W2083291253 cites W2067835344 @default.
- W2083291253 cites W2073791831 @default.
- W2083291253 cites W2079168625 @default.
- W2083291253 cites W2080037651 @default.
- W2083291253 cites W2084230753 @default.
- W2083291253 cites W2091178815 @default.
- W2083291253 cites W2094365136 @default.
- W2083291253 cites W2094898440 @default.
- W2083291253 cites W2101001034 @default.
- W2083291253 cites W2101822881 @default.
- W2083291253 cites W2103372863 @default.
- W2083291253 cites W2105269951 @default.
- W2083291253 cites W2108943513 @default.
- W2083291253 cites W2116516435 @default.
- W2083291253 cites W2120699390 @default.
- W2083291253 cites W2131896212 @default.
- W2083291253 cites W2139169485 @default.
- W2083291253 cites W2143521982 @default.
- W2083291253 cites W2154372868 @default.
- W2083291253 cites W2166739323 @default.
- W2083291253 cites W2324956190 @default.
- W2083291253 cites W2330715420 @default.
- W2083291253 doi "https://doi.org/10.1016/j.ejmech.2013.03.066" @default.
- W2083291253 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3711119" @default.
- W2083291253 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23685570" @default.
- W2083291253 hasPublicationYear "2013" @default.
- W2083291253 type Work @default.
- W2083291253 sameAs 2083291253 @default.
- W2083291253 citedByCount "34" @default.
- W2083291253 countsByYear W20832912532014 @default.
- W2083291253 countsByYear W20832912532015 @default.
- W2083291253 countsByYear W20832912532016 @default.
- W2083291253 countsByYear W20832912532017 @default.
- W2083291253 countsByYear W20832912532018 @default.
- W2083291253 countsByYear W20832912532019 @default.
- W2083291253 countsByYear W20832912532020 @default.
- W2083291253 countsByYear W20832912532021 @default.
- W2083291253 countsByYear W20832912532022 @default.
- W2083291253 countsByYear W20832912532023 @default.
- W2083291253 crossrefType "journal-article" @default.
- W2083291253 hasAuthorship W2083291253A5006261369 @default.
- W2083291253 hasAuthorship W2083291253A5006542271 @default.
- W2083291253 hasAuthorship W2083291253A5007196139 @default.
- W2083291253 hasAuthorship W2083291253A5013186412 @default.
- W2083291253 hasAuthorship W2083291253A5019660090 @default.
- W2083291253 hasAuthorship W2083291253A5038963650 @default.
- W2083291253 hasAuthorship W2083291253A5048007859 @default.
- W2083291253 hasAuthorship W2083291253A5059510963 @default.
- W2083291253 hasAuthorship W2083291253A5062505353 @default.
- W2083291253 hasAuthorship W2083291253A5067011169 @default.
- W2083291253 hasAuthorship W2083291253A5076540388 @default.
- W2083291253 hasAuthorship W2083291253A5077189123 @default.
- W2083291253 hasBestOaLocation W20832912531 @default.
- W2083291253 hasConcept C120750228 @default.